Catalyst Wire Dossier Catalyst Wire Dossier

T-Gel 1%

testosterone gel 1% · Solvay Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-Gel 1%, covering 2015-01-16 to 2015-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism [Phase 2]

See pricing